Aprea Therapeutics
(NASDAQ:APRE)
$5.94
0.04[0.68%]
At close: Apr 12
$5.94
0[0.00%]
After Hours: 5:47PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Aprea Therapeutics Stock (NASDAQ:APRE), Quotes and News Summary

Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.

Open$5.730
Close$5.850
Volume / Avg.5.097K / 34.171K
Day Range5.680 - 5.980
52 Wk Range2.780 - 8.847
Market Cap$32.255M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
2.19%
Days to Cover5.63

Recent News

Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
FDA clearance for Aprea Therapeutics' APR-1051 IND application, a promising WEE1 kinase inhibitor. Phase 1 trial initiation in 2024, focusing on Cyclin E cancers. $34 million private placement to fund clinical development and ensure company sustainability until 2026.
Vandana Singh
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
Why Aprea Therapeutics Shares Hit A New 52-Week Low Today
Aprea Therapeutics Inc (NASDAQ: APRE) shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock. What Else?
Henry Khederian
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Aprea Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and comme...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
APRE
NKGN

FAQ

Q

How do I buy Aprea Therapeutics (APRE) stock?

A

You can purchase shares of Aprea Therapeutics (NASDAQ: APRE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aprea Therapeutics's (APRE) competitors?

A

Other companies in Aprea Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA) and OncoCyte (NASDAQ:OCX).

Q

What is the target price for Aprea Therapeutics (APRE) stock?

A

The latest price target for Aprea Therapeutics (NASDAQ: APRE) was reported by Wedbush on Wednesday, March 27, 2024. The analyst firm set a price target for 11.00 expecting APRE to rise to within 12 months (a possible 88.03% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aprea Therapeutics (APRE)?

A

The stock price for Aprea Therapeutics (NASDAQ: APRE) is $5.85 last updated Today at April 16, 2024 at 3:57 PM EDT.

Q

Does Aprea Therapeutics (APRE) pay a dividend?

A

There are no upcoming dividends for Aprea Therapeutics.

Q

When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?

A

Aprea Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Aprea Therapeutics (APRE) going to split?

A

There is no upcoming split for Aprea Therapeutics.

Q

What sector and industry does Aprea Therapeutics (APRE) operate in?

A

Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch